Abstract:
Oligopeptide compounds or oligopeptide analogue compounds of the formula A-B-D-E-G-J-L-M-Q are ligands for the anaphylatoxin receptor and are useful in the treatment of inflammatory disease states. Also disclosed are anaphylatoxin receptor ligand compositions and a method for modulating anaphylatoxin activity.
Abstract:
Enantiomerically enriched compounds having the absolute stereochemistry of the formula (I) or a pharmaceutically acceptable salt, ester or prodrug thereof, which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caused by microorganisms having a neuraminidase, processes for preparing the compounds and synthetic intermediates used in these processes.
Abstract:
Composés d'oligopeptides ou composés d'analogue d'oligopeptides répondant à la formule ABDEGJLMQ qui sont des ligands pour le récepteur d'anaphylatoxine et qui sont utiles dans le traitement des états pathologiques inflammatoires. Cette invention concerne également des compositions de ligand de récepteur d'anaphylatoxine ainsi qu'un procédé permettant de moduler l'activité de l'anaphylatoxine.